Loading…
← CockpitCompetitor Analysis › LFST Lifestance Health Group, Inc.Open in the cockpit ↗

Lifestance Health Group, Inc.LFSTCompetitor analysis, valuation and peers

United States · USD·Health Care›Medical/Nursing Services

Operator of outpatient mental health clinics providing therapy and psychiatric services across the United States.

Momentum leader 95
Mkt cap
$5.24B
US dollars, full cap
Free float
68%
of shares outstanding
$/day
$98.6M
20-day average traded
Fwd P/E
51.8×
forward earnings
ROIC−WACC
-6.5 pp
WACC 11.3%
Hurdle
+3 pp
Req g minus delivered
Next earnings
105 days
3 Mar 2027
Close · USD$13.77
1D-2.8%
1W-4.2%
1M+12.7%
3M+8.8%
6M+79.3%
YTD+95.6%
1Y+120.3%
ATR %4.6%
Beta0.85
52w lowhigh12.1% off high

What Lifestance Health does

Operator of outpatient mental health clinics providing therapy and psychiatric services across the United States.

Bills insurers for each visit a clinician conducts, so revenue depends on how many clinicians it employs, how many visits each completes and the rates insurers agree to pay. Most patients pay through insurance rather than out of pocket. It built the network by buying small practices, and offers both in-person and video sessions.

Products and services

  • Individual/family therapy
  • Psychiatric medication management
  • Group therapy/specialty programs

Customers

  • Patients seeking mental health care
  • Referring physicians
  • Health insurers

Where it sits in the supply chain

  • Health care services
  • Behavioral/mental health care
  • Outpatient therapy & psychiatry clinics

What could go right

  • Rising mental health care demand
  • De novo clinic and M&A expansion

What could go wrong

  • Clinician recruitment/wage cost pressure
  • Payer reimbursement rate risk

Moat: narrow (scale, distribution). Large multi-state clinician network and payer relationships give scale advantages in a highly fragmented industry.

Headquarters: Scottsdale, Arizona · Founded: 2017 · Employees: 10,961

Named competitors

Lifestance Health at a glance

Size Lifestance Health (LFST) is a United States Health Care company (Medical/Nursing Services) with a market value of $5.24B, the 1145th largest of 3,085 United States companies the cockpit tracks. Shares closed at $13.77 on 18 Nov 2026.

Performance Over six months the shares gained 79.3%, against +15.4% for the median peer and -2.2% for the United States market (cap-weighted) — highest of 20 in its peer set.

Growth Revenue grew 22.6% over the last twelve months (peer median +10.4%); the operating margin is 6.4% (peer median 10.7%).

Valuation It trades at 51.8× forward earnings against a peer median of 20.7× (3rd most expensive of 19).

Price implies For today's price to make sense, revenue must grow about 33% a year for seven years (Req g). Recent delivered growth is +30%, so the hurdle is +3 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 6.5 points below its cost of capital (11.3% WACC).

Short interest Short interest is 3.6% of the free float (30 Oct 2026).

Next results Next results expected around 3 Mar 2027 (exchange calendar; dates can move).

Relative performance

10015020021 May 202621 Aug 202618 Nov 2026LFST 185Peer median 118
Six months, rebased to 100: Lifestance Health against the median of its 20 peers (local-currency closes).

Lifestance Health financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$1.68B$1.42B$1.25B$1.06B$860M
Revenue growth—+14%+19%+23%—
Gross profit$521M$406M$331M$222M$168M
EBITDA$163M$80.5M$40.5M-$107M-$137M
Net income$71.9M$9.66M-$57.4M-$186M-$216M
Free cash flow$179M$110M$85.7M-$57.4M-$26.5M
Capital expenditure$48.3M$36.1M$21.6M$40.5M$79.3M
Total debt$476M$475M$485M$511M$479M

Quarterly statements and history in the cockpit →

Lifestance Health competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-25%0%+25%+50%+75%-40%-20%0%+20%CONRDNTOPCHBLLNHIMSSHLMCOV-BLALPATHLABACHCDVA002044ENSGFMEMDAVAH300015EHCLFST6-month return →1-month return →
Up and to the right = strong over both horizons. Lifestance Health is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%+60%50×100×CONRDNTOPCHBLLNSHLMCOV-BLALPATHLABACHCDVA002044ENSGAVAH300015LFSTRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Lifestance Health is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%+60%0%25%50%75%CONRDNTOPCH3774BLLNSHLMCOV-BLALPATHLABDVAENSGFMELFSTGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Lifestance Health is the large dot.

Lifestance Health competitors and peer comparison

Head to head with its named competitors (LFST vs TALK vs UHS vs ACHC)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Lifestance Health LFST$5.24B+79%+23%6%51.8×33.4%
Talkspace TALKn/a+39%n/an/an/an/a
Universal Health Services UHS$10.7B+13%+8%11%8.3×-1.8%
Acadia Healthcare ACHC$3.49B+56%+4%10%18.6×n/a

How Lifestance Health compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Lifestance Health against its 20 peers (data as of 18 Nov 2026)
MeasureLFSTPeer medianRank in peer set
1-month return+12.7%+2.8%4th highest of 21
6-month return+79.3%+15.4%highest of 20
Distance from 52-week high-12.1%-14.9%10th highest of 21
Revenue growth (TTM)+22.6%+10.4%4th highest of 21
Operating margin6.4%10.7%4th lowest of 21
Forward P/E51.8×20.7×3rd most expensive of 19
Growth the price implies (Req g, 7 yrs)33.4%8.4%3rd most demanding of 19
Growth delivered (Del g)+30.4%+12.5%3rd highest of 19
Hurdle (Req g minus delivered)+2.9 pp-2.1 pp6th most demanding of 19
ROIC minus cost of capital-6.5 pp+3.4 pp3rd lowest of 21
EV / EBITDA33.7×12.1×3rd most expensive of 17
Net debt / EBITDA1.6×2.8×6th least indebted of 19

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Lifestance Health LFSTUnited States$5.24B+79%+23%6%51.8×33.4%+30.4%
Concentra Group Holdings Parent CONUnited States$5.31B+65%+12%17%22.3×3.6%+7.9%
RadNet RDNTUnited States$5.66B+32%+21%5%93.2×38.8%+13.7%
Option Care Health OPCHUnited States$4.75B+43%+4%6%15.7×2.0%+13.2%
Fameglow 3774.HKHong Kong$4.54Bn/a+36%11%n/a57.4%+48.4%
BillionToOne BLLNUnited States$4.37B+7%+72%10%115.3×22.8%+71.9%
Hims & Hers Health HIMSUnited States$4.00B-26%+30%-1%n/an/an/a
Sonic Healthcare SHL.AXAustralia$6.87B+6%+14%9%17.4×9.1%+3.5%
Medicover MCOV-B.STSweden$3.87B+21%+3%7%36.1×19.6%+20.2%
Dr. Lal PathLabs LALPATHLAB.NSIndia$3.53B+15%+17%24%50.5×32.3%+11.8%
Acadia Healthcare ACHCUnited States$3.49B+56%+4%10%18.6×n/an/a
DaVita DVAUnited States$10.2B-18%+6%15%10.1×-2.5%+3.4%
Meinian Onehealth Healthcare 002044.SZChina$2.60B-27%-4%9%49.6×4.2%+5.7%
Ensign ENSGUnited States$10.7B+3%+17%9%21.3×12.7%+16.5%
Fresenius Medical Care FME.DEGermany$11.2B+3%-1%11%9.5×-4.8%+1.9%
Pediatrix Medical MDUnited States$2.41B+37%+2%12%12.4×-4.4%+2.0%
Aveanna Healthcare AVAHUnited States$2.37B+41%+17%12%12.2×7.7%+10.2%
Addus HomeCare ADUSUnited States$2.25B+29%+12%11%16.2×4.0%+13.2%
Aier Eye Hospital 300015.SZChina$12.5B-14%+5%21%30.1×11.8%+13.4%
AddLife ALIF-B.STSweden$2.13B+15%+2%8%39.0×21.1%+14.6%
Encompass Health EHCUnited States$13.2B+27%+9%18%20.1×5.7%+5.0%

Questions

Who are Lifestance Health's main competitors?
Named competitors: Talkspace (TALK), Universal Health Services (UHS), Acadia Healthcare (ACHC). The cockpit's measured peer set (industry) also includes Concentra Group Holdings Parent (CON), RadNet (RDNT), Option Care Health (OPCH), Fameglow (3774.HK), BillionToOne (BLLN), Hims & Hers Health (HIMS).
Is Lifestance Health expensive compared with its peers?
On forward p/e it trades at 51.8× against a peer median of 20.7×, 3rd most expensive of 19 in its peer set. For today's price to make sense, revenue must grow about 33% a year for seven years (Req g). Recent delivered growth is +30%, so the hurdle is +3 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Lifestance Health stock performed?
Over six months to 18 Nov 2026 the shares returned +79.3% against +15.4% for the median peer; over one year +120.3%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.